The postmarketing surveillance of Tadalafil in Japanese patients with pulmonary arterial hypertension.

Trial Profile

The postmarketing surveillance of Tadalafil in Japanese patients with pulmonary arterial hypertension.

Completed
Phase of Trial: Phase IV

Latest Information Update: 15 Jun 2017

At a glance

  • Drugs Tadalafil (Primary)
  • Indications Pulmonary arterial hypertension
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 15 Jun 2017 New trial record
    • 01 May 2017 Results assessing safety (n=1676) and efficacy (n=1556), published in the Current Medical Research and Opinion
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top